Generics - Generics, UK

Filter

Current filters:

GenericsUK

Popular Filters

Cipla to invest £100 million in its UK subsidiary

Cipla to invest £100 million in its UK subsidiary

07-07-2014

Indian drugmaker Cipla has decided to make a significant investment in its UK subsidiary over the next…

CiplaFinancialGenericsMarkets & MarketingResearchUK

Actavis brings escitalopram to market after patent expiry

Actavis brings escitalopram to market after patent expiry

02-06-2014

Generics major Actavis (NYSE: ACT) has launched escitalopram tablets in the UK today, following the patent…

ActavisCNS DiseasesEscitalopramEscitalopram OxalateGenericsLexaproLundbeckPatentsUK

Lilly loses out in UK Alimta vitamin dosage regimen patent law suit

16-05-2014

US pharma major Eli Lilly says that the English High Court has determined that the vitamin dosage regimen…

ActavisAlimtaEli LillyGenericsLegalOncologyPatentsUK

Teva UK launches Lonquex, a new long-acting G-CSF competitor to Amgen drugs

Teva UK launches Lonquex, a new long-acting G-CSF competitor to Amgen drugs

26-02-2014

The local subsidiary of Israeli generics giant Teva Pharmaceutical Industries has launched Lonquex (lipegfilgrastim)…

AmgenBiosimilarsGenericsLonquexMarkets & MarketingNorthern EuropeOncologyTeva Pharmaceutical IndustriesUK

Parexel

Parexel

Back to top